Skip to main content
Log in

Study on growth hormone and insulin secretion in myotonic dystrophy

  • Original Article
  • Published:
The clinical investigator Aims and scope Submit manuscript

Abstract

Growth hormone (GH) levels were measured in 12 patients with myotonic dystrophy (MD; 7 men and 5 women, aged 21–49 years) and 14 volunteers after administration of 100 μg GH-releasing hormone (GHRH; 1–29). A 75-g oral glucose tolerance test was carried out to determine glucose, insulin, plasma C-peptide, and urinary C-peptide. The GH level in six MD patients responded normally to GHRH (group I), with a peak of 17.1 ± 1.46 μg/l, compared withcontrols (27.8 ± 19.6 μg/l, NS), and that in the other six patients responded subnormally, with a peak of 3.15 ± 1.46 μg/l, lower than in controls and in group I patients (P < 0.001). In group I the insulin response to the glucose tolerance test showed hyperinsulinism and was lower than that in group II patients; stimulated C-peptide was also higher in group II than in group I and in controls; urinary C-peptide levels were parallel to those in previous data. In all MD patients there were a negative correlation between absolute values of GH response to GHRH and insulin response to glucose tolerance test (r = - 0.79, P < 0.001). Our data suggest that the failure in GH release and peripheral insulin action is due to a generalized defect in cellular membrane function in MD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

BMI:

body mass index

GH:

Growth hormone

GHRH:

growth hormone releasing hormone

MD:

myotonic dystrophy

References

  1. Aslanidis C, Jansen G, Amemiya C, Crew C, Reardon W, Buckler AJ, Harper PS, Housman DE, Shaw DJ (1992) Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355:545–546

    Google Scholar 

  2. Bando H, Zhang C, Takada Y Yamasaki R, Saito S (1991) Impaired secretion of growth hormone-releasing hormone, growth hormone and IGF-I in elderly men. Acta Endocrinol (Copenh) 124:31–36

    Google Scholar 

  3. Barreca T, Maratorio A, Sannia A, Marri L, Rosi B, Rolandi E (1980) Evaluation of twenty-four-hour secretory patterns of growth hormone and insulin in patients with myotonic dystrophy. J Clin Endocrinol Metab 51:1089–1092

    Google Scholar 

  4. Buxton J, Shelbourne P, Davies J, Jones C, Van Tongeren T, Aslanidis C, de Jong P, Jansen G, Anrret M, Riley B, Williamson R, Johnson K (1992) Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355:547–548

    Google Scholar 

  5. Canal N, Smirne S, Comi G, Guidobono F, Pecile A, Caviesel F (1982) Study of growth hormone and prolactin secretions in myotonic dystrophy. Acta Neurol Belg 82:178–184

    Google Scholar 

  6. Caughey JE, Koochek MH (1974) Growth hormone in dystrophia myotonica. NZ Med J 79:685–687

    Google Scholar 

  7. Culebras A, Podolsky S, Leopold NA (1977) Absence of sleep-related growth hormone elevations in myotonic dystrophy. Neurology 27:290–293

    Google Scholar 

  8. Cudworth AG, Walker BA (1975) Carbohydrate metabolism in dystrophia myotonica. J Med Genet 12:157–160

    Google Scholar 

  9. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diab Care 14:173–194

    Google Scholar 

  10. Fernández-Castafier M, Rosel P, Ricart W, Montaña E, Gómez JM, Navarro MA, Soler Ramón J (1987) Evaluation of B-cell function in diabetics by C-peptide determination in basal and posprandial urine. Diabete Metab 13:538–542

    Google Scholar 

  11. Gómez-Sáez JM, Fernández-Real JM, Navarro MA, Martínez-Matos JA, Soler J (1993) GH secretion status in myotonic dystrophy. Psychoneuroendocrinol 18:183–190

    Google Scholar 

  12. Grey JE, Gitelman HJ, Roses AD (1980) Myotonic muscular dystrophy. Defective phospholipid metabolism in the erythrocyte plasma membrane. J Clin Invest 65:1478–1482

    Google Scholar 

  13. Griggs RC, Kingston W, Llerr BE (1985) Lack of relationship of hypogonadism to muscle wasting in myotonic dystrophy. Arch Neurol 42:881–885

    Google Scholar 

  14. Harley HG, Brook DJ, Rundle SA, Shtler C, McHadern M, Tsilfidis C, Chen C, Alleman J, Wormskamp NGM, Vooijs M, Buxton J, Johnson K, Sneets MJM, Lenon GG, Carrano AV, Kormelak RG, Wibringa B, de Jong PJ (1992) Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 355:548–551

    Google Scholar 

  15. Krentz AJ, Williams AC, Nattrass M (1991) Insulin resistance in multiple aspects of intermediary metabolism in myotonic dystrophy. Metabolism 8:866–872

    Google Scholar 

  16. Lleuriken OA, Sundsfford JA, Myberg-Hansen R (1978) Evaluation of endocrine functions in dystrophia myotonica. Acta Neurol Scand 58:178–189

    Google Scholar 

  17. Moxley RT, Griggs RC, Goldblatt D (1978) Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. J Clin Invest 62:857–867

    Google Scholar 

  18. Moxley III RT, Griggs RC, Goldblatt D (1980) Muscle insulin resistance in myotonic dystrophy: effect of supraphysiologic insulinization. Neurol 30:1077–1083

    Google Scholar 

  19. Moxley III RT, Griggs AJ, Minaker KL, Rowe JW (1984) Whole body insulin resistance in myotonic dystrophy. Ann Neurol 15:157–162

    Google Scholar 

  20. Moxley III RT, Kingston WJ, Griggs RC, Livinston JM(1987) Lack of rapid enhancement of insulin action after oral glucose challenge in myotonic dystrophy. Diabetes 36:693–701

    Google Scholar 

  21. Okimura Y, Chihara K, Kita T, Kashio Y, Sato M, Kitajima N, Abe H, Takahashi K, Fujita T (1988) Discordance between growth hormone (GH) responses after GH-releasing hormone and insulin-induced hypoglycemia in myotonic dystrophy. J Clin Endocrinol Metab 67:1074–1079

    Google Scholar 

  22. Pizzi A, Fusi S, Forti G, Marconi G (1985) Study of endocrine function in myotonic dystrophy. Ital J Neurol Sci 6:457–467

    Google Scholar 

  23. Pizzuti A, Friedman DL, Caskey T (1993) The myotonic dystrophy gene. Arch Neurol 50:1173–1179

    Google Scholar 

  24. Suzuki H (1981) Hyperglucagonemia in myotonic dystrophy. J Clin Endocrinol Metab 52:790–796

    Google Scholar 

  25. Tevaarwerk GJM, Hudson AJ(1977) Carbohydrate metabolism and insulin resistance in myotonia dystrophica. J Clin Endocrinol Metab 44:491–496

    Google Scholar 

  26. Wong P, Roses AD (1979) Isolation of an abnormally phosphorylated membrane band 3 glycoprotein from patients with myotonic muscular dystrophy. J Membr Biol 45:147–166

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: J. M. Gomez Saez

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gómez Sáez, J.M., Fernández Real, J.M., Fernández Castañer, M. et al. Study on growth hormone and insulin secretion in myotonic dystrophy. Clin Investig 72, 508–511 (1994). https://doi.org/10.1007/BF00207479

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00207479

Key words

Navigation